Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Coliseum Capital Keeps Buying Accuride Stock

Accuride stock, Coliseum: Coliseum Capital Management LLC., a major shareholder at Accuride Corporation (NYSE:ACW), purchased 38,112 shares worth approximately $191,703 this week. Coliseum owns 13.46% of the company with a position of 4,976,194 shares in total, representing a capital value of $25,180,000. The purchase was completed through one transaction, it is the second deal carried out this week, and the largest one of the two.

Accuride logo

The transaction was accomplished by Coliseum Capital with the same modus operandi of the first, namely, multiple trades. Hence, the average price is calculated to be around $5.03 per share, or $0.47 less than last Monday’s transaction. The latest was also way above the 15,519 shares bought at the beginning of the week.

Coliseum Capital’s latest purchase does not seem out of the ordinary. The corporation is by far the largest shareholder for Acurride, counting almost three times the amount of shares the following partner holds. Additionally, purchases have exponentially increased through this year. The month of July, especially, saw lots of transactions in favor of the corporation.

After the transactions occurred in July, stock price rose to $6.66, the 52 week-high. Although stock price dropped to yesterday’s low of $5.02 at closing, it remains above the $4.80 tag price paid in July. The transactions made in August showed smaller earnings when compared to with current price, but allowed the company to turn into a major shareholder. The real winning made by the company, was accomplished during the first quarter with a strong rise of stock price.

Besides Coliseum, Jim Simons has recovered his trust in Acurride and bought 159,160 shares. It is not his first time with a position, nor is the largest position ever held by the guru.

Disclosure: Jodor Jalit holds no position in any of the mentioned stocks.

Recommended Reading:

Ferrellgas Insider Buying Activity Heats Up

Jacobs Entertainment Begging for a Buyout: There’s Something You Don’t See Everyday

Unifirst CEO Ronald Croatti Was Buying At $91

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!